News and Announcements
Blue Sky Biologicals Announces High Volume Manufacturing Agreement
- Published November 10, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Blue Sky Biologicals will produce a CBD based pain relief product for Soverign Funds Pty Ltd for the Australian Pharmaceutical marketplace.
- Marks one of the largest CBD production agreements in Australia
- Sovereign to market the Blue Sky manufactured product globally.
Vancouver, BC, November 8, 2017 – Blue Sky Biologicals Inc. (“BlueSky”) is pleased to announce that it has signed a Heads of Agreement (“HOA”) with Sovereign Funds Pty. Ltd. (“Sovereign”) of New South Wales, Australia for the production of Sovereign’s proprietary pain relief formulation.
With its GMP standard processing facility and the largest cannabidiol (CBD) and cannabinoid production capacity in the world, BlueSky will meet the rigorous specifications set by Sovereign while also fulfilling the volumes required.
“We are very pleased to be able to work with Sovereign to produce and supply their groundbreaking, CBD-based pain relief formula, CannadeineTM. Blue Sky Biologicals will continue to provide a completely organic and sustainable supply of industrial hemp-based CBD formulations to Sovereign to match their market growth” said Wade Hobson, Executive Vice President of BlueSky, managing the Asia Pacific region.
“Sovereign will now have the ability to distribute large volumes of their innovative pain relief products through a regulated pharmacy program, marking a milestone in the Australian medicinal marketplace, in compliance with the stringent Australian regulatory regime now in place for import and production” said Hobson.
About BlueSky
BlueSky is a vertically integrated global leader in CBD’s produced from its organic, hand harvested industrial hemp fields. BlueSky manufactures its CBD’s without the use of hexane or propylene glycol, maintaining high levels of purity through the entire product portfolio. BlueSky provides a full range of products within the four categories of Dietary Supplements, Personal Care, Functional Foods/Beverages and an exclusive Pet Care line.
About Sovereign
Sovereign is a producer of CBD and cannabinoid medicines. Sovereign is the proprietor of CannadolTM and CannadeineTM, which are the worldwide trademarks of their CBD medicine that derives from a stable breed and has a unique combination of cannabinoids for pain relief as well as prompt beneficial relief of many conditions and serious ailments.
Company Updates
Tony Seba’s “Stellar Abundance” – A Roadmap for Strategic Investment in the Next Exponential Growth Era
In a recent conversation with Herbert Ong on the “Brighter with Herbert” YouTube channel, visionary author and co-founder of RethinkX and Stellar, Tony Seba, outlines a profoundly ambitious and positive outlook on the future, making recent market analyses of substantial changes seem comparatively minor. While the focus often remains on the growing opportunities within specific […]
Fundraising Realities and Strategic Engagement Imperative
Sydney-based CapitalHQ, a platform founded by Steve Torso of Wholesale Investor, has reached its first anniversary, a milestone marked by a notable shift in its operational model. Torso, in a recent address, not only celebrated this juncture but also provided a grounded assessment of the prevailing challenges in capital raising, advocating for a more strategic […]
Hong Kong: Your Strategic Launchpad into Asia’s High-Growth Markets
Explore the unique benefits Hong Kong offers as a strategic launchpad for companies looking to access the high-growth markets of Mainland China and Southeast Asia, leveraging its favorable business environment and international connections.
Backed By Leading Investment Groups and Family Offices
